Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression (Q38941672)

7 September 2017

title

Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression (English)

1 reference

7 September 2017

1 reference

Y-L Hsu

1

1 reference

7 September 2017

J-Y Hung

2

1 reference

7 September 2017

S-H Chou

3

1 reference

7 September 2017

M-S Huang

4

1 reference

7 September 2017

M-J Tsai

5

1 reference

7 September 2017

Y-S Lin

6

1 reference

7 September 2017

S-Y Chiang

7

1 reference

7 September 2017

Y-W Ho

8

1 reference

7 September 2017

C-Y Wu

9

1 reference

7 September 2017

P-L Kuo

10

1 reference

7 September 2017

language of work or name

English

0 references

publication date

10 November 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

31

1 reference

7 September 2017

page(s)

4056-4068

1 reference

Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Management of non-small-cell lung cancer: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Angiomotin regulates endothelial cell-cell junctions and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The Angiomotins--from discovery to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Regulation of the Hippo pathway and implications for anticancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

TAZ is a novel oncogene in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Hippo pathway-independent restriction of TAZ and YAP by angiomotin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The EMT regulator slug and lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Transcriptional regulation of cell polarity in EMT and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Zonula occludens-1 and -2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

YAP is a candidate oncogene for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

YAP oncogene overexpression supercharges colon cancer proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Emerging roles of TEAD transcription factors and its coactivators in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

The EDA-containing cellular fibronectin induces epithelial-mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K/AKT and Erk1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.333

Tumor-associated antigen L6 and the invasion of human lung cancer cells

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25381822

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25381822

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2014.333

1 reference

Dimensions Publication ID

7 September 2017

1003297849

0 references

1 reference